Given Imaging, Olympus settle video pill row:
This article was originally published in Clinica
Endoscopy rivals Given Imaging and Olympus have settled a patent litigation suit in the US concerning the companies' pill-sized diagnostic cameras. The two firms signed a term sheet for the settlement of the litigation which will see Yoqneam, Israel-based Given receive a payment of $2.33m. All past legal action between the two firms has been dropped and the companies agreed not to sue over devices that are currently available. This settlement sees both parties gain a cross-licence under existing and future patents for any future capsule endoscopy products, which may include the payment of royalties. Both companies have also agreed to co-operate in future joint marketing development projects. Given originally filed a patent litigation lawsuit against Olympus in October 2006, not long after Olympus launched its Endo Capsule small bowel visualisation device in Europe.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.